Disclosures for "Native Methylation Sequencing for Detection and Monitoring of Alzheimer’s Disease, Parkinson’s and ALS "
-
Dr. Hill has received personal compensation for serving as an employee of Wasatch Biolabs. Dr. Hill has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Renew Biotechnology. Dr. Hill has or had stock in Wasatch Biolabs.Dr. Hill has or had stock in Pioneer Biolabs.Dr. Hill has received research support from NIH. Dr. Hill has received research support from Utah State Alzheimer's Fund. Dr. Hill has received research support from Society for Developmental Biology. Dr. Hill has received research support from Fulbright Commission. Dr. Hill has received research support from Renew Biotechnologies. Dr. Hill has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Pollard has received personal compensation for serving as an employee of Renew Biotechnologies. Mr. Pollard has stock in Renew Biotechnologies. Mr. Pollard has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Miller has received personal compensation for serving as an employee of Resonant. Mr. Miller has stock in Inherent Biosciences. Mr. Miller has received intellectual property interests from a discovery or technology relating to health care.
-
Mrs. Zimmerman has received personal compensation for serving as an employee of Renew Biotechnologies.
-
Dr. Jenkins has received personal compensation for serving as an employee of Renew Biotechnologies. Dr. Jenkins has stock in Renew Biotechnologies. The institution of Dr. Jenkins has received research support from Renew Biotechnologies. The institution of Dr. Jenkins has received research support from NIH. Dr. Jenkins has received intellectual property interests from a discovery or technology relating to health care.